Millennium developing lymphoma drug - Boston Globe
Millennium developing lymphoma drugBoston GlobeMillennium Pharmaceuticals, a division of Takeda Pharmaceutical Co., of Japan, said it will develop and market a lymphoma drug with ...Seattle Genetics sells non-US drug rights to TakedaReutersTakeda To Commercialize Seattle Genetics lymphoma Program Brentuximab Vedotin ...RTT NewsMillennium Gains Seattle's Late-Stage lymphoma Drug with Initial $60M FeeGenetic Engineering News (press release)BioWorld Online�-Mass High Tech�-Xconomyall 55 news articles��
Blog Content
Post a Comment